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ABSTRACT
The Nrf2 (nuclear factor E2 p45-related factor 2)
transcription factor responds to diverse oxidative
and electrophilic environmental stresses by circum-
venting repression by Keap1, translocating to the
nucleus, and activating cytoprotective genes. Nrf2
responses provide protection against chemical
carcinogenesis, chronic inflammation, neuro-
degeneration, emphysema, asthma and sepsis in
murine models. Nrf2 regulates the expression of a
plethora of genes that detoxify oxidants and electro-
philes and repair or remove damaged macromol-
ecules, such as through proteasomal processing.
However, many direct targets of Nrf2 remain un-
defined. Here, mouse embryonic fibroblasts (MEF)
with either constitutive nuclear accumulation
(Keap1
 / ) or depletion (Nrf2
 / ) of Nrf2 were
utilized to perform chromatin-immunoprecipitation
with parallel sequencing (ChIP-Seq) and global tran-
scription profiling. This unique Nrf2 ChIP-Seq
dataset is highly enriched for Nrf2-binding motifs.
Integrating ChIP-Seq and microarray analyses, we
identified 645 basal and 654 inducible direct
targets of Nrf2, with 244 genes at the intersection.
Modulated pathways in stress response and cell
proliferation distinguish the inducible and basal
programs. Results were confirmed in an in vivo
stress model of cigarette smoke-exposed mice.
This study reveals global circuitry of the Nrf2
stress response emphasizing Nrf2 as a central
node in cell survival response.
INTRODUCTION
Nuclear factor E2 p45-related factor 2 (symbol Nfe2l2;
commonly called Nrf2), a basic-region leucine zipper tran-
scription factor (TF), binds to the cis-regulatory, antioxi-
dant response element (ARE) and transcriptionally
upregulates an environmental stress response gene
battery (1). The Nrf2 response is critical for protection
against pulmonary inﬂammation and emphysema,
asthma, acute lung injury, hyperoxia, pulmonary
ﬁbrosis, innate immune response, hepatotoxicity, carcino-
genesis, neurodegeneration, cardiovascular disease and
aging (2–11). A decline in the Nrf2 pathway is associated
with severe chronic obstructive pulmonary disease
(COPD) (12–15). In addition, several classes of small mol-
ecules such as 1,2-dithiolethiones (e.g. oltipraz), isothio-
cyanates (e.g. sulforaphane) and triterpenoids (e.g.
CDDO-Im) induce expression of Nrf2 target genes and
protect against chemical carcinogenesis, acute hepatotox-
icity and cigarette smoke (CS)-induced emphysema
(16–19). On the other hand, studies show that many
cancers such as non small cell (NSCLC) and squamous
cell lung tumors develop inactivating mutations in the
Keap1 and Nrf2 genes, respectively, thereby constitutively
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tumorigenecity and resistance to an array of
chemotherapeutic compounds (20,21). Hence, due to the
dual role of Nrf2 in carcinogenesis and degenerative
chronic diseases and the diversity of target genes under a
variety of stresses, understanding the pathway compo-
nents and regulators is critical for eﬀectively targeting
the pathway for prophylactic and therapeutic purposes.
Gene-expression proﬁling studies using diﬀerent tissue
and cell-culture systems exposed to diverse conditions
(chemical or environmental) reveal the pleiotropic
properties of Nrf2 in stress response and cell survival.
Keap1 (Kelch ECH associating protein 1), a cytosolic re-
pressor of the Nrf2 pathway, plays a central role in regu-
lation of the Nrf2 response. Under normal conditions,
Nrf2 is targeted by Keap1, which promotes Nrf2
proteasomal degradation via interactions with an ubiqui-
tin ligase (22). Keap1 further functions as a sensor of
stress signals, through stress-induced oxidation of key
cysteine residues that lead to conformational changes
and the inability to bind Nrf2 (23). Nrf2 then accumulates
in the nucleus, where it binds to AREs in a heterodimeric
complex with one of a subset of the small Maf-family of
TFs (24,25).
Using Nrf2-knockout (Nrf2
 / ) murine models in dif-
ferent organs and with various stressors, Nrf2 was found
to coordinately regulate a suite of targets genes such as
antioxidant genes, xenobiotic-metabolizing enzymes,
many of which have been traditionally classiﬁed as part
of the phase II detoxiﬁcation system, glutathione homeo-
stasis, solute channels, proteome maintenance and innate
immune response (8,26–32). Disruption of Keap1
(Keap1
 / ) leads to enhanced nuclear accumulation of
Nrf2 and elevated expression of Nrf2-regulated genes
(33). Largely, the Nrf2 regulated genes are associated
with pathways related to cell survival—batteries of
proteins that provide protection against a variety of oxi-
dative and electrophilic stressors.
Although, many genes are regulated in an Nrf2-
dependent manner, no large-scale studies have distin-
guished between direct and indirect targets of Nrf2, the
latter perhaps emerging from Nrf2 cross-talk with other
signaling pathways (34–36). In this report, we evaluated
the concordance between global mRNA expression
proﬁles at the transcriptomic levels (i.e., oligonucleotide
microarray analyses) and genome-wide Nrf2-DNA-
binding analysis using high-throughput methodologies
(ChIP-Seq). This approach is important for establishing
a systems level view of Nrf2-dependent processes
occurring within cells. In the ChIP-Seq analysis, over
1200 Nrf2-bound regions were observed from Keap1
 / 
MEFs. These regions were strongly enriched for
Nrf2-binding site patterns, with the motifs clustered near
the maxima of the ChIP-Seq peaks. The gene-expression
analysis identiﬁed 7155 genes signiﬁcantly downregulated
in Nrf2
 /  compared with wild-type (WT) MEFs (basal
targets) and 7832 signiﬁcantly upregulated genes in
Keap1
 /  compared with WT MEFs (inducible targets),
with 2489 modulated genes intersecting between the two
datasets (common targets). Integrating the results from
ChIP-Seq and expression proﬁling data, signatures were
observed for gene groups that include detoxiﬁcation
response, cell proliferation, cell cycle and survival regula-
tion networks. Strikingly, the proliferation and stress
responses segregate between the direct Nrf2 target expres-
sion classes, with proliferation linked to basal expression
and detoxiﬁcation linked to inducibleactivation. The
high-throughput results were validated using quantitative
real-time polymerase chain reaction (qRT-PCR) and
site-speciﬁc ChIP assays in MEFs and CS-exposed
mouse lungs to demonstrate the Nrf2 response in vivo.
The integrated analysis of the experimental data highlights
the broad inﬂuence of Nrf2, providing a blueprint for the
regulation of cytoprotective genes and genes involved in
critical homeostatic function such as cell proliferation.
MATERIALS AND METHODS
Growth and viability of mouse embryonic ﬁbroblasts
WT, Keap1
 / , and Nrf2
 /  cell lines, were generated as
described previously (33). Cells were grown to 90%
conﬂuency in 100-mm plates in Iscove’s modiﬁed
Dulbecco’s medium (Invitrogen, CA) containing 10%
FBS. Cells were harvested and processed for microarray
and chromatin immunoprecipitation (ChIP) analyses as
described below. Cell viability was assessed using the
MTT assay as described previously (33).
CS exposure
WT and Nrf2
 /  male mice (CD-1 strain, 8–10weeks)
were exposed to CS for 5h/day using a TE-10 smoking
machine (Teague Enterprises, Davis, CA) and 3R4F ref-
erence cigarettes (University of Kentucky, Tobacco
Research Institute, Lexington, KY) as described previ-
ously (8). The study protocols were approved by the
Johns Hopkins Institutional Review Board for animal
studies.
ChIP
The ChIP was performed as described previously (37).
MEFs were ﬁxed  1% formaldehyde in cell growth
media for 10min followed by glycine ﬁxation. Cells were
then sonicated in ChIP–lysis buﬀer containing protease
inhibitor cocktail after incubation on ice for 30min.
Upon sonication, the samples were spun at maximum
speed for 12min in a cold microcentrifuge. The super-
natants were then addressed to as Input samples. A part
of the input sample was precleared using 50% slurry of
Protein A/G beads prepared in immunoprecipitation (IP)
buﬀer for 2h in cold, following which the beads were
centrifuged out and supernatant was used for IP. Then
the precleared samples were incubated with 2mgo f
either of two distinct anti-Nrf2 antibodies that recognize
diﬀerent portions of Nrf2 protein. The rabbit-anti-Nrf2
monoclonal antibody from Epitomics Inc., CA, recognizes
the C-terminal domain in all three cell lines, while the
rabbit-anti-Nrf2 polyclonal antibody from Santa Cruz
Biotech., CA, recognizes domains spanning the
N-terminus in all three cell lines as well. For control, we
Nucleic Acids Research, 2010,Vol.38, No. 17 5719used anti-rabbit IgG antibody for 1h in cold. These
antibodies have been used extensively in our laboratory
for western and EMSA analysis [Figure 1A(i) and data not
shown]. Protein A/G bead slurry was added to each
reaction and was rotated overnight. Next day, beads
were washed extensively, DNA was reverse crosslinked
and eluted in elution buﬀer and stored at  80 C until
used for sequencing or PCR validation assays. The
eluted DNA was checked for 100- to 300-bp fragment
enrichments using 8% polyacrylamide gel electrophoresis
(data not shown).
Massive parallel sequencing
We generated two DNA libraries using two Nrf2-speciﬁc
antibodies [one monoclonal, rabbit-anti-Nrf2 (Epitomics
Inc., CA), and one polyclonal, rabbit-anti-Nrf2 (Santa
Cruz Biotech., CA)] incubated with crosslinked and
sonicated DNA from Keap1
 /  MEFs. A third control
library contains the input DNA from Keap1
 /  MEFs.
The sequencing and reads alignment to the mouse
genome (NCBI build 37) was performed at the Genome
Science Centre (Vancouver, Canada) as described previ-
ously (38).
ChIP-Seq library peak ﬁnding
To identify signiﬁcant Nrf2-bound regions in the data we
used the FindPeaks software (39) with the following par-
ameters: Triangle dist.=100 low/200 median/300 high;
Sub-peaks=0.8; Trim-peaks=0.2; Filter
Duplicates=On; Filter out reads quality lower than 10.
The false discovery rate estimation (FDR) was based on a
Lander-Waterman calculation integrated in the FindPeaks
software. An artifactual cluster of peaks was found at the
beginning of chromosome 11 in all three libraries and was
discarded from the analysis.
Peak overlap determination between the three ChIP-Seq
libraries
The peak height is deﬁned by the number of tags
overlapping at a speciﬁc genomic location. All peaks
above a height of 5 from each of the three libraries were
considered in this analysis. Peaks were considered as
overlapping when their maximum heights were located
within 100bp of each other.
Peak sequence extraction and analysis
One hundred nucleotides on each side of the peak
maximum height location were extracted from the
EnsEMBL database using Perl scripts. These sequences
were analyzed for A, C, G, T and dinucleotide content.
For the background, the sequences were extracted simi-
larly for all peaks with a height  5 and only the ones with
a composition similar to the Nrf2 ChIP-Seq peak se-
quences were retained.
To plot the peak distribution relative to transcription
start sites (TSS), the closest TSS from each peak was ex-
tracted from the EnsEMBL database using Perl scripts
and the distance computed.
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Figure 1. Nrf2 genome-wide ChIP-Seq dataset. (A) Keap1
 /  MEFs have constitutive transcriptional activation of Nrf2 target genes (i) Nuclear Nrf2
protein levels in Keap1
 / , WT and Nrf2
 /  MEFs using immunoblot analysis, (ii) ChIP–PCR and densitometry quantiﬁcation analysis for known
Nrf2-binding site in promoter of Nqo1 and Gsta3, (iii) qRT-PCR analysis of known Nrf2 targets, Nqo1 and Gsta3 and (iv) Immunoblot analysis for
Nqo1 and Gsta3 in the MEFs. b-Actin was used as the loading control. (B) The distribution of Nrf2 ChIP-Seq peaks relative to the closest gene
transcription start sites is similar to background. (C) Nrf2 ChIP-Seq peaks are enriched for high-scoring Nrf2 predicted motifs compared with
background. (D) High-scoring predicted sites are preferentially located near the peak maximum height in the ChIP-Seq peaks whereas they are
uniformly distributed in the background sequences. *P-value<0.01, as analyzed by ANOVA analysis.
5720 Nucleic Acids Research, 2010,Vol.38, No. 17The Nrf2-binding site prediction was performed by
scanning each sequence with the Nrf2-binding proﬁle
based on known binding sites (Figure 2A) using the
TFBS Perl modules (40). For the peaks containing a pre-
dicted site with a score at least equal to 0.85, the absolute
distance from the closest end of the site to the peak
maximum height position was computed.
Statistical analysis
The statistical signiﬁcance of the diﬀerences observed
between the Nrf2 ChIP-Seq dataset and the background
were computed using a Wilcoxon rank sum test with con-
tinuity correction using the R package. The Fisher’s exact
test demonstrating greater overlaps than expected by
chance between various datasets were performed using
the ﬁsher. test() function in the R package with the
option alternative=‘greater’.
Transcription factor-binding site overrepresentation
We used a modiﬁed version of the oPOSSUM system (41)
in which the overrepresentation is calculated directly on
the ChIP-Seq sequences rather than on conserved regions
located around user-speciﬁed genes. The overrepre-
sentation was calculated through the comparison with
the background sequences from the control library. The
binding proﬁles were extracted from the JASPAR 2008
Figure 1. Continued.
Nucleic Acids Research, 2010,Vol.38, No. 17 5721vertebrate core collection (42) using a score threshold
of 80%.
MEME motif discovery analyses
The MEME web service (http://meme.sdsc.edu) was ran
with the following options: -dna -mod zoops -nmotifs 1
-minw 6 -maxw 50 -time 7200 -maxsize 60000–revcomp.
The obtained motifs were compared with the original
Nrf2-binding proﬁle using the online STAMP service
(http://www.benoslab.pitt.edu/stamp/). Motifs were
aligned using the Smith–Waterman algorithm and
compared with the Pearson Correlation Coeﬃcient simi-
larity measure.
Figure 1. Continued.
Table 1. Overlap of Nrf2 ChIP-Seq peaks with known Nrf2-binding
sites annotated in the PAZAR database (http://www.pazar.info)
Gene symbol PAZAR
annotation
ChIP-Seq peak
Fth1 RS0144992 Overlaps known BS
Ftl1 RS0144993 Overlaps known BS
Gsta3 RS0145004 Overlaps known BS
Gstp1/Gstp2 RS0145008 Overlaps known BS
Mafg RS0145006 Overlaps known BS
Nqo1 RS0145007 Overlaps known BS
Txn1 RS0144999 Overlaps known BS
Gclc RS0144994 Overlaps known BS + Additional peak
Hmox1 RS0145005 Overlaps known BS + Additional peak
Txnrd1 RS0145000 Overlaps known BS + Additional peak
Abcc1 RS0144989 Nearby known BS
Abcc2 RS0145001 Nearby known BS
Ets1 RS0144991 Nearby known BS
Gclm RS0144995 Nearby known BS
Akr1b3 RS0145002 No peak
Gnai2 RS0144996 No peak
Gpx2 RS0144997 No peak
Gsta1 RS0145003 No peak
Nqo2 RS0144998 No peak
Akr1c1 RS0144990 Mouse ortholog diﬃcult to assign
A  [10   0   0  20   0   6   5  16   0   0  15 ]
C  [ 1   0   0   0  17   2  10   0   0  20   2 ]
G  [ 9   0  19   0   1   1   1   2  20   0   2 ]
T  [ 0  20   1   0   2  11   4   2   0   0   1 ]
A  [278   0   0 410  14  52  26 329   3   3 346 ]
C  [ 23   2   0   0 287  11 315   2   3 398  13 ]
G  [103   0 400   0  74  11  30  47 404   6  15 ]
T  [  6 408  10   0  35 336  39  32   0   3  36 ]
IC = 14.4
IC = 15.1
B
A
Figure 2. Nrf2-binding proﬁles. (A) The original Nrf2-binding proﬁle
was deﬁned by the alignment of the 20 known binding sites described
in Table 1. (B) The motif generated by the MEME motif discovery algo-
rithm (50) on the Nrf2 ChIP-Seq dataset is highly similar to the original
proﬁle with a higher information content (IC; in bits). The position
Frequency Matrix (PFM) captures the count of each nucleotide found
at each position in the motif and the logo provides a visualization of the
data. The information content is the sum of the information content of
each position and is computed as described previously (61).
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Total RNA was puriﬁed using the RNeasy Mini kit
(Qiagen, Valencia, CA) after isolation using TRIzol
reagent (Life Technologies, Inc., Grand Island, NY).
Murine Genome MOE 430A GeneChip arrays
(Aﬀymetrix, Santa Clara, CA), which contain probes for
detecting  14500 well-characterized genes and 4371 ex-
pressed sequence tags (ESTs) were used to probe the
RNA obtained from the cells using the procedure
described previously (10).
Microarray data analysis
Data analysis was performed using open source ‘R’
Statistical software (version 2.6.1) through the
Bioconductor project (43). The raw data ﬁles were
loaded using aﬀy package while probe intensities and nor-
malizations were done using Robust Multichip Averaging
(gcRMA) method. The ﬁrst approach was to test the
internal consistency and to explore the relationship
among samples and underlying features of gene expression
comparing 21536 unique gene probe sets across three rep-
licates for control and treatment. The corresponding
gene names and annotation information was extracted
from ‘mouse4302’ annotation package provided by
Bioconductor. Diﬀerential expression analysis was con-
ducted using SigniEcance Analysis of Microarray (SAM)
using the same R statistical package (version 1.25). SAM
calculates a score for each gene on the basis of the change
in expression relative to the standard deviation of all
measurements by computing a t-statistic. SAM then
performs a set of permutations to determine the false dis-
covery rate (FDR) with adjustment method for multiple
testing. The reported list of ranked genes have a ‘delta
value’ which deﬁnes the threshold of false positive in the
validated dataset, which was adjusted to a stringent FDR
<1 (44). Seed Clustering was performed with set seeds
(determined from diﬀerential expression analysis and
known active AREs). The seed clustering calculates a
distance matrix between genes and based on indicated
seeds (clusters), places the gene with the minimum
distance to a seed into the seed’s cluster.
Validation of ChIP-Seq data by ChIP–PCR
Selected peaks from promoters of genes from diﬀerent
functional groups were validated by ChIP–PCR for
selected regions. Primers were selected on both strands a
100bp from the Nrf2 ChIP-Seq peaks. The same
immunoprecipitated DNA as analyzed in the ChIP-Seq
assay was used for PCR ampliﬁcation using the speciﬁc
gene promoter PCR assay. PCR primers for each of the
PCR reaction are shown in Supplementary Table S1. PCR
ampliﬁcations were carried out with a 95 C denaturation
step for 5min followed by 35 cycles with a cycle consisting
of 95 C denaturation for 30s, 58 C annealing step for 45s
and 72 C extension step for 45s each, followed by a ﬁnal
elongation step at 72 C for 7min. The PCR products were
then run on a 1.2% Agarose gel and visualized with
ethidium bromide staining. The data are represented as
the relative ChIP signal in a cell line. They are calculated
by taking the ratio of fold diﬀerence in (PCR ampliﬁcation
in speciﬁc antibody ChIP samples as compared with PCR
ampliﬁcation with genomic DNA input sample in each cell
line) versus (PCR ampliﬁcation in IgG samples for each
cell line as compared with PCR ampliﬁcation with
genomic DNA input in that respective cell line). The sig-
niﬁcance of ChIP signal in Keap1
 /  or Nrf2
 /  cell lines
are calculated as compared with WT cells using Student’s
t-test and represented at P-value<0.01.
Validation of microarray data by qRT-PCR
Selected genes from diﬀerent functional groups were
validated by qRT-PCR. Total RNA from cells used for
microarray was puriﬁed using the Qiagen RNeasy kit
(Qiagen, Valencia, CA) for mRNA isolation. qRT-PCR
was then performed using Assay-on-Demand primers and
probe sets from Applied Biosystems (Foster City, CA) as
described previously (10). We used the ABI 7000 Taqman
system (Applied Biosystems) to perform these assays.
b-actin was used as a normalization control. The mRNA
data are represented as relative fold change (RFC). RFC
are calculated as the ratio of target gene expression
(fold change of particular gene mRNA expression in
experimental sample/control sample) versus (fold
change of b-actin mRNA expression in experimental
sample/control sample). Control sample for MEF
gene-expression data are WT MEFs and WTAir for
mice mRNA expression data.
Cell proliferation assay
Cell proliferation was measured by Quantos
TM cell prolif-
eration assay (Stratagene, La Jolla, CA) and cell prolifer-
ation ELISA, BrDU chemiluminescence assay (Roche
Applied science, Indianapolis, IN) as per manufacturer’s
instructions.
Caspase activity assay as a marker of cell death
Caspase activity for caspase-3 and -7 was measured using
Apo-ONE homogeneous caspase-3 and -7 assay kit
(Promega, WI).
Cell senescence assay
Cell senescence was measured using a ﬂuorimetric assay to
examine senescence associated beta-galactosidase activity
from Cell Biolabs Inc. CA.
Immunoblot assay
Immunoblots were performed using antibodies for Nrf2,
Srxn1, Cdkn1a, Cdkn2a (Santa Cruz Biotechnology, CA),
Nqo1, Gsta3, Txnrd1, Gsta4, Gstm1, Als2, Bmpr1a,
Igf1, Npnt, Pdgfc, Vegfc (Abcam Inc., MA). b-actin and
Lamin B1 (Santa Cruz Biotechnology, CA) were used as
loading controls. These immunoblots were performed
using protocols as described previously with Nrf2,
Srxn1, Cdkn1a, Cdkn2a and b-actin primary antibodies
used at 1:500 dilution; Nqo1, Gsta3, Txnrd1, Gsta4,
Gstm1, Als2, Bmpr1a, Igf1, Npnt, Pdgfc, Vegfc used at
1:200 dilution while Lamin B1 (b-Lamin) was used at
1:1000 dilutions (13).
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Genetic model of Nrf2 activation
MEFs derived from Keap1
 / , Nrf2
 / , as well as WT
mice were used as models in our studies. Nrf2 is constitu-
tively elevated in nuclei of Keap1
 /  MEFs as compared
with WT or Nrf2
 /  MEFs [Figure 1A(i)]. Consequently,
Nrf2 target site (ARE) binding, as observed by ChIP
[Figure 1A(ii)] and Nrf2-regulated transcriptional
activity, measured as target gene mRNA expression by
qRT-PCR [Figure 1A(iii)] and protein expression by
immunoblot [Figure 1A(iv)], are signiﬁcantly higher in
Keap1
 /  MEFs when compared with WT and Nrf2
 / 
MEFs. There is basal nuclear translocation of Nrf2 in WT
MEFs at low levels that leads to expression of a subset of
Nrf2 targets which will be referred to as basal Nrf2
targets. This is the case for Gsta3, which displays Nrf2
binding to its promoter in WT MEFs and diﬀerential ex-
pression between WT and Nrf2
 /  MEFs [Figure 1A(ii–
iv)]. In contrast, Nqo1 is an inducible target of Nrf2, as
Nrf2 binds to its promoter and selectively induces its ex-
pression only in Keap1
 /  MEFs [Figure 1A (ii–iv)].
Genome-wide identiﬁcation of Nrf2 target sites
We performed a ChIP-Seq experiment with Keap1
 / 
MEFs, in which Nrf2 is protected from ubiquitination
and degradation, constitutively activating the expression
of Nrf2 target genes. We generated two DNA libraries
using two Nrf2-speciﬁc antibodies (one monoclonal and
one polyclonal). A third control library contains the input
DNA. We obtained 13998222, 14068662, and 16375760
mapped reads for the polyclonal, monoclonal and control
libraries, respectively. Clusters of overlapping tags were
identiﬁed as peaks using the FindPeaks software (39).
Peak height thresholds were identiﬁed for each library cor-
responding to a stringent FDR  0.001. The monoclonal
antibody selected library was of superior quality. A
peak-height threshold of nine speciﬁed the required
stringency with 1128 peaks meeting the criteria
(Supplementary Table S2). In contrast, the polyclonal
antibody selected library required a threshold of 11 to
achieve the stringency with only 271 peaks meeting the
criteria (Supplementary Table S2). Only 40 of the 271
peaks were unique to the polyclonal library. We focused
on the monoclonal collection. A ﬁnal set of 886 mono-
clonal peaks not overlapping the control library peaks
were selected for further analysis. As the polyclonal
library is complementary to the monoclonal library, we
added those peaks that overlapped between the two
libraries (peak height 5) but were absent from the
control library (370 peaks). This resulted in a total of
1256 ChIP-Seq peaks representing a high-conﬁdence set
of Nrf2-binding sites. In addition to these nuclear
genome-wide Nrf2-binding sites, we identiﬁed nine signiﬁ-
cant Nrf2 ChIP-Seq peaks in the mitochondrial genome.
These peaks represent the ﬁrst report of Nrf2 transcrip-
tional activity in the mitochondria. They were not
included in the bioinformatics sequence analyses below
because of the diﬀerent properties of the nuclear and mito-
chondrial genomes.
To conﬁrm the quality of the results, we assessed the
recovery of bona ﬁde Nrf2-binding sites in the human,
mouse or rat genomes compiled from the literature into
the PAZAR regulatory annotation repository (18). Ten of
the corresponding mouse regions overlap one of the
ChIP-Seq peaks and while four do not overlap a peak, a
peak can be found in proximity (Table 1, Supplementary
Figure S1). This ﬁnding of 50% sensitivity (considering
only the peaks that strictly overlap a site) is highly signiﬁ-
cant (Fisher’s exact test; P<2.2e–16) and is a strong in-
dication of the quality of the results, all the more so as the
literature derived studies were performed in a variety of
species and cell types.
Focusing on 201-bp sequences (100-bp ﬂanking each
side of the maximum height position), we determined
that these sequences exhibit a nucleotide composition
bias with 57% (A or T), 43% (G or C) and a ratio of
[CG]/[C or G] of 0.024. Thus, we selected the background
sequences from the control library with similar compos-
ition and obtained a control sample of 5225 sequences
with an overall composition of 56% (A or T), 44% (G
or C), and a ratio of [CG]/[C or G] of 0.027.
Comparing the positional distribution of the 1256
Nrf2-binding sites with the 5225 background sequences
relative to the closest gene transcription start site (TSS)
showed no signiﬁcant diﬀerence (Figure 1B). The concen-
tration bias in favor of proximal TSS observed in both the
Nrf2 and control sequence sets is likely a reﬂection of the
open chromatin state of these regions making the DNA
more susceptible to breakage in the shearing step of the
procedure. Similar enrichment bias for transcription start
regions has been reported as systematic in ChIP-Seq ex-
periments (45). Similarly, the chromosomal distribution of
the peaks showed no signiﬁcant diﬀerence with the back-
ground (data not shown).
Nrf2-binding site motifs are enriched within the
ChIP-Seq identiﬁed regions. A binding proﬁle reﬂecting
the properties of the literature-derived Nrf2-binding site
collection was constructed (Figure 2A). Figure 1C displays
the distribution of the top scoring matches to the
Nrf2-binding proﬁle in the Nrf2 peaks and the control
peaks. The background shows a normal distribution
centered around a score of 0.8 (Figure 1C). The score
distribution for the Nrf2 bound peaks is skewed towards
higher scoring sites with more than 55% of the sequences
presenting Nrf2 sites with a score  0.85, a stringent
threshold (Figure 1C), and is signiﬁcantly diﬀerent from
the background (Wilcoxon rank sum test; P<2.2e–16).
Binding site predictions suﬀer from high rates of false
positives (46), as evident in the 7% of control peaks con-
taining an Nrf2 proﬁle match with a score  0.85. A pos-
itional bias was observed in the positive collection
(Figure 1D). In the 707 Nrf2 ChIP-Seq peaks that have
a predicted Nrf2-binding site scoring at least 0.85, 65%
contain the site within 22bp of the peak maximum height,
whereas in the 379 background sequences, the sites
are distributed uniformly across the sequences. The diﬀer-
ence proves statistically signiﬁcant (Wilcoxon rank
sum test; P<2.2e–16). In conclusion, the results
demonstrate that the Nrf2 ChIP-Seq dataset is highly
enriched for Nrf2-binding sites as deﬁned by the
5724 Nucleic Acids Research, 2010,Vol.38, No. 17enriched presence and positional distribution of Nrf2-
binding site motifs.
Binding site enrichment is a powerful tool to identify
relationships between characterized TFs and sets of genes
or sequences determined from genome-scale proﬁling ex-
periments. In addition to the dramatic enrichment for
Nrf2-binding sites, we observed enrichment for Fos and
Mafb-binding sites within the Nrf2 collection (Table 2).
This result is consistent with the fact that Nrf2 is known to
heterodimerize with Maf proteins (47) and a subset of
Nrf2-binding sites have been shown to overlap AP-1
response elements, AP-1 being a complex composed of
Fos and Jun proteins (48).
To investigate whether the current binding model for
Nrf2 (Figure 2A)—the model used to predict the binding
sites in the above analyses—reﬂects the data contained in
the Nrf2 ChIP-Seq dataset, we ran a motif discovery
analysis on the 1256 sequences. Motif discovery software
is extremely sensitive to noise (49). Thus, we focused our
analysis on the 45-bp region central to the peaks as we had
determined that most true binding sites were located
within  22bp of the peak maximum (Figure 1D). We
used the MEME motif discovery tool (50) to perform
the analysis of these sequences and obtained a motif
very similar to the original one (Figure 2B,
E-value=4.996e–15). The most remarkable diﬀerence
lies in the central TC pattern that is stronger in the
ChIP-Seq data and leads to an overall stronger proﬁle
(higher information content; Figure 2) that could lead to
more speciﬁc predictions.
Microarray based Nrf2 genome-wide target selection
and characterization
Genome-wide microarray experiments were performed to
identify both basal and inducible Nrf2 target genes. Basal
Nrf2 target genes are transcribed in untreated normal cells
and are thus expected to be downregulated in Nrf2
 / 
MEFs as compared with WT (Figure 3A). Inducible
Nrf2 targets are transcribed in response to stress condi-
tions (such as oxidative stress), when Nrf2 is released from
Keap1 repression, and are thus expected to be upregulated
in Keap1
 /  MEFs compared with WT (Figure 3A). From
diﬀerential expression experiments, we identiﬁed 7155
genes signiﬁcantly downregulated in Nrf2
 /  compared
with WT MEFs (‘basal’) and 7832 signiﬁcantly
upregulated genes in Keap1
 /  compared with WT
MEFs (‘inducible’) (Figure 3B). Focusing on the intersec-
tion of the two sets, 2489 genes are both basally expressed
and inducible, referred to as ‘common’ targets
(Figure 3B).
Integrated analysis of Nrf2 direct target genes
We hypothesized that genes directly modulated by Nrf2
would contain a ChIP-Seq peak in their vicinity and show
altered regulation in the microarray studies. We extracted
the ﬂanking genes, from both sides, of the Nrf2 ChIP-Seq
peaks totaling 1738 genes. We identiﬁed 654 unique genes
overlapping between ChIP-Seq and basal Nrf2 target
dataset (genes downregulated in Nrf2
 /  versus WT com-
parison, 7155 genes) (Supplementary Table S3, Figure 3C)
and 645 genes overlap between ChIP-Seq and inducible
Nrf2 targets (genes upregulated in Keap1
 /  versus WT
comparison, 7832 genes) (Supplementary Table S4, Figure
3C). The intersection of the peak-ﬂanking genes with the
2489 basal and inducible expression modulated genes is
statistically signiﬁcant (Fisher’s exact test; P=3.469e–
06) with an integrated set of 244 genes (Supplementary
Table S5, Figure 3C).
The MEME motif discovery analysis described above
was ran on the ChIP-Seq peak sequences located near
each of the three Nrf2 target gene subsets (basal, inducible
and common), but no signiﬁcant diﬀerence was observed
in the obtained proﬁle.
Gene Ontology (GO) term over-representation analyses
were performed for ‘basal’ and ‘inducible’ groups inde-
pendently using the DAVID annotation analysis system
(51) and identiﬁed term enrichment for biological
processes. Of important note, the inducible and basal
gene sets exhibited distinct maximally enriched processes,
with ‘cell proliferation’ dominating the basal genes and
‘response to oxidative stress’ the most prominent and
only statistically-signiﬁcant for the inducible genes (see
Supplementary Tables S6 and S7 for 654 basal and 645
inducible target genes, respectively). In addition to the
regular GO over-representation analysis, DAVID
provides a clustering function that forms sets of
Table 2. TFBS overrepresentation in the Nrf2 ChIP-Seq peaks using the oPOSSUM system and the vertebrate JASPAR proﬁles
TF TF Class Background
gene hits
Target
gene hits
Background
TFBS rate
Target
TFBS rate
Z-score Fisher score
NRF2 bZIP 1222 849 0.0144 0.0546 169.7 5.94E–185
Fos bZIP 3566 1063 0.0449 0.0736 69.97 1.87E–31
Mafb bZIP, MAF 4125 1081 0.0604 0.0839 49.77 5.23E–08
Lhx3 HOMEO 2066 610 0.0219 0.0331 38.67 1.28E–08
MEF2A MADS 1192 344 0.0124 0.0165 18.4 6.47E–04
Cebpa bZIP 2706 704 0.0421 0.0492 17.99 7.36E–03
CREB1 bZIP 1121 313 0.0143 0.0178 14.98 6.74E–03
HNF1A HOMEO 435 143 0.006 0.0083 14.91 6.79E–04
IRF1 TRP-CLUSTER 1220 338 0.0157 0.0194 14.8 6.90E–03
Myf bHLH 1765 472 0.0238 0.0283 14.79 9.90E–03
ESR1 NUCLEAR RECEPTOR 76 33 0.0013 0.0023 14.43 4.39E–03
NFIL3 bZIP 1034 296 0.012 0.0146 12.2 2.68E–03
Only signiﬁcant hits are reported (Z-score >10 and Fisher score <0.01).
Nucleic Acids Research, 2010,Vol.38, No. 17 5725overlapping gene categories, again highlighting ‘response
to stress’ and ‘cell proliferation’ for the two categories
(Table 3).
Under the hypothesis that Nrf2 is part of a broader
regulatory network and needs the cooperation of other
TFs to regulate the expression of its target genes, we per-
formed TF-binding site (TFBS) over-representation
analyses of the Nrf2 ChIP-Seq peak sequences associated
with the basal and inducible target gene sets (Table 4). We
ﬁrst masked out in the sequences all Nrf2 predicted sites
with a score 0.8 to focus our search on the other motifs
present in the sequences. In both the basal and inducible
datasets, we identiﬁed two signiﬁcant signatures from a
homeodomain and a MADS TF (Table 4). Interestingly,
many homeodomain TFs are part of the Nrf2 basal and/or
inducible target gene sets, three of them, Dlx2, Pbx1 and
Meis1, being present in both and therefore candidates to
participate in the Nrf2 regulatory network.
Antioxidant and detoxiﬁcation networks regulated by Nrf2
For validation analysis we focused on the 244 genes, rep-
resenting the Nrf2 targets regulated under basal as well as
inducible conditions. Our results demonstrate an
upregulation of many antioxidant and xenobiotic detoxi-
ﬁcation genes in response to the de-repression of Nrf2, the
most commonly described function of this TF (Figure 4A
and B). These results expand our knowledge of Nrf2 regu-
lation of these pathways by inclusion of novel direct
targets as well as by identiﬁcation of the DNA-binding
sites in the respective promoters. Members of the glutathi-
one system that function to scavenge reactive oxygen
species and preserve cellular redox balance (such as Gsr
and Gpx2) (52,53) are direct transcriptional targets of
Nrf2.
We validated the known binding sites for Nqo1, Gsta3
and Txnrd1 and an additional upstream site as direct
Nrf2-binding site (Txnrd1_P2) [Figures 1A(ii, iii), 4A
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5726 Nucleic Acids Research, 2010,Vol.38, No. 17and B]. In addition, we identiﬁed and validated
Nrf2-binding sites in promoters of known cytoprotective
Nrf2 target genes such as Gsta4, Gstm1, Gstm3 and Srxn1
along with the less known targets Ephx1 and Als2
(Figure 4A and B). DNA-binding results as analyzed by
ChIP–PCR directly corresponded with greater mRNA ex-
pression of the respective genes in Keap1
 /  and/or WT
MEFs as compared with Nrf2
 /  MEFs (Figure 4C).
However, in the case of Gstm1 and Als2, the microarray
and ChIP–PCR results were not entirely validated by the
qRT-PCR as the diﬀerence in Nrf2 binding between
Keap1
 /  and WT MEFs did translate into a signiﬁcant
diﬀerence in gene expression in the microarray but not in
the qRT-PCR. This discrepancy between our high-
throughput and PCR gene-expression data may be a
result of the diﬀerential sensitivities of the techniques
involved.
As a means for further conﬁrmation of target genes, we
assessed the protein expression levels of selected genes by
immunoblot (Figure 4D). Immunoblots of Txnrd1 and
Srxn1corroborate them as inducible targets while Gstm1
and Als2 were validated as basal-only targets and Gsta4
was conﬁrmed as a common- target (Figure 4D).
To conﬁrm our results in an in vivo stress-regulated
model, we analyzed the expression patterns of these
genes in the lungs of 1-day CS-exposed mice from WT
and Nrf2
 /  (Nrf2
 / CS) mice compared with their air
controls (WTAir and Nrf2
 / Air). In this model, Nrf2
basal targets are genes downregulated in Nrf2
 / 
air-exposed cells compared with WT air-exposed cells,
and inducible targets are genes upregulated in
CS-exposed WT cells compared with air-exposed WT
cells. The antioxidant and xenobiotic detoxiﬁcation
genes identiﬁed as Nrf2 direct targets in the MEF
genetic model were validated in qRT-PCR assays to be
Nrf2 targets in mouse lungs exposed to CS-induced
stress, thereby highlighting the physiological importance
of the identiﬁed targets (Figure 4E).
Regulators of cell proliferation, cell cycle and survival
networks as transcriptional targets of Nrf2
The compilation of the ChIP-Seq and gene-expression
proﬁling analyses identiﬁed component genes of the cell
proliferation/survival pathways as well as cell-cycle regu-
lators such as Cdkn2b. Using ChIP–PCR and qRT-PCR
analyses for DNA binding on the identiﬁed sites and
mRNA probes respectively, we validated several of these
genes as direct transcriptional targets of Nrf2 (Figure 5A,
B and C). Cell proliferation regulators such as Als2
(Figure 4) and Npnt (Figure 5A and B) were found to
Table 3. Functional clustering of gene annotations using the DAVID resource reveals an enrichment for genes involved in cell proliferation in
the basal target gene set and glutathione metabolism, involved in response to stress, in the inducible target gene set
Category Term Count Percentage P-value FDR
Top cluster for the set of 654 basal target genes (Geometric mean: 5.23E–6)
GOTERM_BP_4 GO:0042127 regulation of cell proliferation 33 5.05 7.47E–07 1.27E–03
GOTERM_BP_4 GO:0008284 positive regulation of cell proliferation 21 3.21 9.00E–06 1.53E–02
GOTERM_BP_4 GO:0048522 positive regulation of cellular process 54 8.26 2.12E–05 3.61E–02
Top cluster for the set of 645 inducible target genes (Geometric mean: 1.03E–3)
KEGG_PATHWAY mmu00480:Glutathione metabolism 10 1.55 6.85E–05 8.54E–02
INTERPRO IPR003081:Glutathione S-transferase, Mu class 5 0.78 1.07E–04 2.07E–01
PIR_SUPERFAMILY PIRSF000503:glutathione transferase 7 1.09 1.56E–04 2.82E–01
GOTERM_MF_4 GO:0004364 glutathione transferase activity 7 1.09 2.80E–04 4.02E–01
INTERPRO IPR012335:Thioredoxin fold 11 1.71 5.19E–04 1.00
INTERPRO IPR004045:Glutathione S-transferase, N-terminal 6 0.93 1.37E–03 2.62
INTERPRO IPR004046:Glutathione S-transferase, C-terminal 6 0.93 1.37E–03 2.62
SP_PIR_KEYWORDS Dimer 4 0.62 3.57E–03 5.39
KEGG_PATHWAY mmu00980:Metabolism of xenobiotics by cytochrome P450 9 1.40 1.06E–02 12.4
COG_ONTOLOGY Posttranslational modiﬁcation, protein turnover, chaperones 11 1.71 1.17E–01 73.2
Table 4. TFBS over-representation in subsets of Nrf2 ChIP-Seq peaks associated with basal and inducible target genes using the oPOSSUM
system and the vertebrate JASPAR proﬁles
TF TF class Background
gene hits
Target
gene hits
Background
TFBS rate
Target
TFBS rate
Z-score Fisher score
ChIP-Seq peaks associated with the Nrf2 basal target genes
Lhx3 HOMEO 2039 333 0.0218 0.0341 30.81 2.59E–05
MEF2A MADS 1179 196 0.0125 0.0182 18.68 1.56E–03
HNF1A HOMEO 424 81 0.006 0.009 14.49 2.41E–03
NFIL3 bZIP 1009 168 0.0118 0.0155 12.72 3.57E–03
ChIP-Seq peaks associated with the Nrf2 inducible target genes
Lhx3 HOMEO 2039 306 0.0218 0.0321 25.15 1.81E–03
MEF2A MADS 1179 185 0.0125 0.0179 17.28 4.72E–03
All NRF2 predicted sites >80% are masked in foreground and background.
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5728 Nucleic Acids Research, 2010,Vol.38, No. 17be basal- targets of Nrf2 by ChIP–PCR and were con-
ﬁrmed as basal- only targets of Nrf2 by qRT-PCR and
immunoblot assays (Figures 4, Figure 5C and D). Other
cell proliferation associated genes as Bmpr1a, Igf1, Itgb2,
Jag1 and Pdgfc were found to be inducible targets of Nrf2
as assessed by ChIP–PCR (Figure 5A and B). In contrast,
the microarray analyses (as well as the qRT-PCR for
Bmpr1a and Igf1) deﬁned these genes as common Nrf2
targets. The gene-expression change is much greater
between Keap1
 /  and WT MEFs than between Nrf2
 / 
and WT MEFs and the latter might thus be due to sec-
ondary eﬀects rather than direct Nrf2-binding changes.
Additional evaluation of target gene expression using
protein expression analysis conﬁrms Bmpr1a, Igf1 and
Vegfc as common targets, Pdgfc and Cdkn1a as inducible
targets and Npnt as a basal-only target (Figure 5D). Next,
as Cdkn2b is a part of this integrated gene set, we looked
through all the Nrf2 ChIP-Seq dataset for additional
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Figure 5. Cell proliferation genes and cell-cycle regulators are direct transcriptional targets of Nrf2. (A) and (B) ChIP–PCR and densitometry
quantiﬁcation analysis for cell proliferation genes and Cdkn genes—Cdkn1a, Cdkn2b-binding site (Cdkn2b_P1), comparing Keap1
 / , WT and
Nrf2
 /  MEFs. (C) qRT-PCR for mRNA expression analysis of proliferation genes and Cdkns respectively. (D) Immunoblot analysis for Bmpr1a,
Igf1, Npnt, Pdgfc, Vegfc CDKN1A and CDKN2A in MEFs. b-Actin was used as the loading control. (E) Quantos
TM Cell proliferation assay.
(F) BrdU chemiluminescence assay. (G) Caspase activity (apoptosis) assay. (H) Cell senescence assay. (I) qRT-PCR for mRNA expression in lung
lysates from WT and Nrf2
 /  Air and CS exposed mice corroborating with the in vitro Nrf2 targets. *P-value<0.01 as compared with control and
yP-value<0.01 as compared with WT at the same time point, as analyzed by ANOVA analysis.
Nucleic Acids Research, 2010,Vol.38, No. 17 5729cell-cycle regulators and identiﬁed Cdkn1a and Cdkn2a,
none of them being diﬀerentially regulated in the micro-
array analysis. Using ChIP–PCR and qRT-PCR assays,
Cdkn1a (p21) and Cdkn2b (p15) were found to be direct
inducible targets of Nrf2, on the other hand, Cdkn2a (p16)
does not appear to be a direct Nrf2 target (Figure 5A, B
and C). Immunoblot analysis conﬁrms Cdkn1a as an in-
ducible target of Nrf2 while no change in protein expres-
sion of Cdkn2a was observed similar to the qRT-PCR
results (Figure 5C and D). We checked whether the
changes in the gene expression of these cell proliferation
and survival promoting genes translated into increased
proliferation of Keap1
 /  and WT cells when compared
with Nrf2
 /  cells. Corroborating the gene-expression
results, we found a signiﬁcant increase in proliferation of
Keap1
 /  as well as WT cells as compared with Nrf2
 / 
cells under normal conditions as analyzed by increased
DNA content quantiﬁed by Quantos
TM cell proliferation
assay and increased BrdU uptake assessed by BrDU
chemiluminescence assay respectively (Figure 5E and F).
Recent publications have emphasized the role of Nrf2 in
promoting cell proliferation and cell-cycle progression
(17,41), but this report is the ﬁrst to broadly characterize
the direct role of Nrf2 in executing the regulatory program
governing proliferation. Since, Cdkn1a and Cdkn2b are
traditionally considered as cell-cycle inhibitors and
inducers of apoptosis or senescence; we sought to distin-
guish if their induction promoted inhibition of cell prolif-
eration or induction of cell death or senescence in
Keap1
 /  cells. We found no diﬀerential induction of
apoptosis or senescence, while there was a relative
increase in proliferation in Keap1
 /  cells when
compared with WT or Nrf2
 /  cells (Figure 5G and H).
Regulation of Cdkns as direct targets and components of
Nrf2 stress response remains a very interesting ﬁnding and
its implications on cellular physiology remain to be
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Figure 6. Summary of Nrf2-regulated global transcriptomics circuit. This Nrf2 interaction network was generated using the String interaction
network analysis tool (http://string.embl.de). The genes represented are the basal (black), inducible (white) and common (grey) target genes
associated with cell proliferation and/or glutathione metabolism as deﬁned by the functional clusters obtained through the DAVID resource and
described in Table 3.
Nucleic Acids Research, 2010,Vol.38, No. 17 5731unraveled. These genes were also validated as Nrf2 targets
in vivo in mice lungs under CS-induced stress (Figure 5I).
These two observations implicate novel probable roles for
Cdkn1a and Cdkn2b in Nrf2-regulated cell survival and/
or proliferation.
DISCUSSION
We have described a genome-scale analysis of the regula-
tory network governed by the Nrf2 TF using a combin-
ation of high-throughput sequencing for ChIP and
microarray-based gene-expression proﬁling. The genome-
scale experiments were performed with MEFs isolated
from mice lacking Keap1, the key mediator of Nrf2 deg-
radation, and mice lacking Nrf2 as well as WT mice. The
results agree with the recognized role of Nrf2 in regulating
the expression of protective genes that attenuate cytotox-
icity in response to chemical toxins, and reveal a strong
role for Nrf2 in the direct regulation of cellular prolifer-
ation. The segregation of ‘cell proliferation’ gene enrich-
ment to a basal gene-expression cluster contrasts with
‘stress response’ enrichment in an inducible cluster. An
unbiased binding proﬁle derived from the experimental
data extends a previous model for the binding speciﬁcity
of Nrf2. The validity of the high-throughput results were
conﬁrmed by independent ChIP and qRT-PCR assays. To
conﬁrm the functional relevance of the ﬁndings in the
transgenic cells, the results were conﬁrmed using lung
samples from mice exposed to concentrated CS in com-
parison to air controls. These ﬁndings represent the ﬁrst
comprehensive genome-wide study of Nrf2 binding and,
coupled with the expression proﬁling, reveal the broad
role of Nrf2 in protecting cells against toxic conditions.
The central role of Nrf2 in activating protective gene
expression is long recognized, but its role in the regulation
of cell proliferation has received less attention. Studies
on the control of cellular diﬀerentiation in both adipocytes
(54) and osteoblasts (55) have indicated that activa-
tion of the Nrf2 pathway can inhibit diﬀerentiation.
Given the relationship between the maintenance of a
proliferative state and the cell cycle, these studies are
suggestive of a link between Nrf2 and the cell cycle. Our
own studies have shown a potential link between Nrf2 and
the oxidative-stress induced inhibition of proliferation
(56,57). The current study also allows for speculation
about novel roles of Nrf2 pathway in regulation of
diseases. For example, Nrf2 target gene, Pdgf is involved
in a prenatal placental disorder, preeclampsia, because of
increasing levels of their antagonist, fms-like tyrosine
kinase 1 (Flt1) (58,59). In addition, Nrf2 regulated gene
expression has been linked previously with vascular
homeostasis and oxidative stress response in endothe-
lial and smooth muscle cells in protection against
diseases such as atherosclerosis and preeclampsia (60).
These observations along with our data on positive regula-
tion of Pdgf by Nrf2 indicate a more important role of
Nrf2 pathway in developmental diseases such as
preeclampsia.
The segregation of ‘proliferation’ targets and ‘stress’
targets to genetically distinct expression groups is
noteworthy. The distinction suggests a potential complex-
ity to the Nrf2 regulatory network (Figure 6). The analysis
of transcription factor motif over-representation did not
reveal an enriched binding site for any TF that segregates
between the sets. It is possible that the distinction results
from an alternative mechanism such as a microRNA
activity.
The Nrf2 pathway has been studied in diverse tissue
contexts, due to potential roles in stroke recovery,
COPD and cancer prevention in multiple organs. The
proﬁling of gene-expression changes mediated by the
Nrf2 pathway has been well documented. The interpret-
ation of such studies, however, has been hampered
by the inability to distinguish genes modulated directly
by Nrf2 from genes induced secondarily by Nrf2-sensitive
TFs. The availability of the ChIP-Seq technology and
a high-quality antibody have provided this ﬁrst oppor-
tunity to intersect the two classes of genomic data and
consequently deﬁne direct gene targets of the pathway.
The genomic regions directly bound by Nrf2 in the
vicinity of Nrf2-responsive genes constitute a rich
starting set for the study of Nrf2 regulation. The down-
stream analysis of such target regions could reveal here-
tofore under-appreciated properties of the elements that
could distinguish inducible cis-regulatory elements from
other sequences bound by Nrf2 with no functional
outcome.
The development of a high-throughput ChIP-Seq pro-
cedure provides a direct path for future experimental
studies. As the cost of ChIP-Seq experiments declines, it
will be possible to perform temporal studies of binding in
response to inducing conditions and to perform compara-
tive analyses of responses between diﬀerent tissues. Such
studies will be an important focus as researchers seek to
discern the tissue-speciﬁc properties of the pathway and
identify functional targets for interventions, both
to induce the protective enzymes in healthy tissue and to
suppress the system in cancer cells where the pathway has
become deregulated.
The identiﬁcation of a well-deﬁned Nrf2 regulatory
program is a critical step in advancing translational
research. Nrf2 plays an important role in the susceptibility
to COPD and other diseases; moreover, it protects cells
against a variety of environmental stressors and carcino-
gens. Thus, the full discovery of the global circuitry of
Nrf2 as a master protector is a signiﬁcant step in our
understanding of its function.
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